user

The efficacy and toxicity of 4-day chemotherapy with methotrexate, etoposide and actinomycin D in patients with choriocarcinoma and high-risk gestational trophoblastic neoplasia

被引：0
|
作者：
Shizuka Sato
Eiko Yamamoto
Kaoru Niimi
Kazuhiko Ino
Kimihiro Nishino
Shiro Suzuki
Tomomi Kotani
Hiroaki Kajiyama
Fumitaka Kikkawa
机构：
[1] Nagoya University Graduate School of Medicine,Department of Obstetrics and Gynecology
[2] Nagoya University Graduate School of Medicine,Department of Healthcare Administration
[3] Wakayama Medical University,Department of Obstetrics and Gynecology
来源：
International Journal of Clinical Oncology | 2020年 / 25卷
关键词：
Actinomycin D; Choriocarcinoma; Etoposide; High-risk gestational trophoblastic neoplasia; Methotrexate;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：203 / 209
页数：6
相关论文
共 50 条
  • [41] Comparing and Evaluating Five-Day Chemotherapy Agents Actinomycin D and Methotrexate in Low-Risk Post-Molar Gestational Trophoblastic Neoplasia: A Retrospective Analysis
    Xu, Juan
    Wang, Xinmei
    Qu, Pengpeng
    [J]. CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY, 2022, 49 (05):
  • [42] Can carboplatin or etoposide replace actinomycin-D for second-line treatment of methotrexate resistant low-risk gestational trophoblastic neoplasia?
    Ribeiro Mora, Paulo Alexandre
    Sun, Sue Yazaki
    Velarde, Guillermo Coca
    Rezende Filho, Jorge
    Uberti, Elza H.
    Vieira dos Santos Esteves, Ana Paula
    Elias, Kevin M.
    Horowitz, Neil S.
    Braga, Antonio
    Berkowitz, Ross S.
    [J]. GYNECOLOGIC ONCOLOGY, 2019, 153 (02) : 277 - 285
  • [43] The efficacy evaluation of initial chemotherapy for high-risk gestational trophoblastic neoplasm
    Li, Yitong
    Chen, Dan
    Yu, Huihui
    Xia, Rong
    Zhang, Xin
    Zheng, Wei
    [J]. CURRENT PROBLEMS IN CANCER, 2022, 46 (03)
  • [44] TREATMENT OF HIGH-RISK GESTATIONAL TROPHOBLASTIC DISEASE WITH CHEMOTHERAPY COMBINATIONS CONTAINING CISPLATIN AND ETOPOSIDE
    THEODORE, C
    AZAB, M
    DROZ, JP
    ASSOULINE, A
    GEORGE, M
    PIOT, G
    BELLET, D
    MICHEL, G
    AMIEL, JL
    [J]. CANCER, 1989, 64 (09) : 1824 - 1828
  • [45] Management and Survival of Patients with FIGO High-risk Gestational Trophoblastic Neoplasia
    Agarwal, Roshan
    Alifrangis, Costi
    Everard, Janet
    Savage, Philip M.
    Short, Dee
    Tidy, John
    Fisher, Rosemary A.
    Sebire, Neil J.
    Harvey, Richard
    Hancock, Barry W.
    Coleman, Robert E.
    Seckl, Michael J.
    [J]. JOURNAL OF REPRODUCTIVE MEDICINE, 2014, 59 (1-2) : 7 - 12
  • [46] EMA-CO chemotherapy for high-risk gestational trophoblastic neoplasia: a clinical analysis of 54 patients
    Lu, W. -G.
    Ye, F.
    Shen, Y. -M.
    Fu, Y. -F.
    Chen, H. -Z.
    Wan, X. -Y.
    Xie, X.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2008, 18 (02) : 357 - 362
  • [47] Treatment results of the second-line chemotherapy regimen for patients with low-risk gestational trophoblastic neoplasia treated with 5-day methotrexate and 5-day etoposide
    Kanno, Toshiyuki
    Matsui, Hideo
    Akizawa, Yoshika
    Usui, Hirokazu
    Shozu, Makio
    [J]. JOURNAL OF GYNECOLOGIC ONCOLOGY, 2018, 29 (06)
  • [48] Salvage chemotherapy of relapsed or high-risk gestational trophoblastic neoplasia (GTN) with paclitaxel/cisplatin alternating with paclitaxel/etoposide (TP/TE)
    Wang, J.
    Short, D.
    Sebire, N. J.
    Lindsay, I.
    Newlands, E. S.
    Schmid, P.
    Savage, P. M.
    Seckl, M. J.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 (09) : 1578 - 1583
  • [49] Serum human chorionic gonadotropin ratios for the detection of etoposide, methotrexate, dactinomycin, cyclophosphamide, and vincristine resistance in high-risk gestational trophoblastic neoplasia
    Sirimusika, Nathapol
    Boonyapipat, Sathana
    [J]. HEALTH SCIENCE REPORTS, 2022, 5 (04)
  • [50] Prognostic Factors Associated with hCG Remission and Chemotherapy Resistance in Patients with High-Risk Gestational Trophoblastic Neoplasia
    S. V. Tejas
    V. R. Pallavi
    K. Shobha
    S. K. Rajshekhar
    [J]. Indian Journal of Gynecologic Oncology, 2022, 20
12345